BioVersys AG (CHIX:BIOVZ) Inventories, Work In Process: CHF0.00 Mil (As of Dec. 2025)


CHIX:BIOVZ BioVersys AG CHIX:BIOVZ
14 GF Score
Price CHF27.10
View Full Analysis

What is BioVersys AG Inventories, Work In Process?

BioVersys AG CHIX:BIOVZ 14 Inventories, Work In Process is CHF0.00 Mil as of Dec. 2025. GuruFocus rates CHIX:BIOVZ with a GF Score™ of 14/100.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. BioVersys AG's work in process for the quarter that ended in Dec. 2025 was CHF0.00 Mil.

BioVersys AG Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for BioVersys AG's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVersys AG Inventories, Work In Process Chart

BioVersys AG Annual Data
Trend Dec24 Dec25
Inventories, Work In Process
0.00 0.00

BioVersys AG Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
Inventories, Work In Process 0.00 0.00 0.00 0.00
CHIX:BIOVZ
14GF Score
BioVersys AG CHIX:BIOVZ
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioVersys AG Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of CHF0.00 Mil mean?
BioVersys AG (CHIX:BIOVZ) has a Inventories, Work In Process of CHF0.00 Mil as of Dec. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on BioVersys AG and its competitors.
Is BioVersys AG's Inventories, Work In Process too high?
BioVersys AG's current Inventories, Work In Process is CHF0.00 Mil. Overall, BioVersys AG has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's Inventories, Work In Process compare to VRTX and REGN?
BioVersys AG's Inventories, Work In Process of CHF0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on BioVersys AG and its competitors. BioVersys AG's current Inventories, Work In Process is CHF0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (CHIX:BIOVZ) has a current Inventories, Work In Process of CHF0.00 Mil. The current Inventories, Work In Process is CHF0.00 Mil. BioVersys AG's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For BioVersys AG (CHIX:BIOVZ), the current Inventories, Work In Process is CHF0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioVersys AG Business Description

Other Exchanges W33:GermanyBIOV:Switzerland
Address c/o Technologiepark, Hochbergerstrasse 60c, Basel, CHE, CH-4057
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
14GF Score

Get the complete analysis for CHIX:BIOVZ

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF27.10
Price